Aekyung Chemical Co., Ltd. Overview
Aekyung Chemical is the chemicals arm of Korea's Aekyung Group, formed in November 2021 by merging Aekyung Petrochemical, Aekyung Chemical and AK ChemTech. It is Korea's largest producer of phthalic anhydride and plasticizers, and also makes unsaturated polyester and coating resins, surfactants, refined glycerin, biodiesel and bio-heavy oil. Revenue peaked at KRW 2.18 trillion in FY2022 and fell to KRW 1.45 trillion in FY2025, when Chinese overcapacity in commodity plasticizers pushed the company into its first post-merger operating loss (KRW −10.2 bn). Management's answer is a shift toward higher-value materials: Korea's first terephthaloyl chloride (TPC) plant for aramid fibre (15,000 t/yr, completed March 2026), hard-carbon anode material for sodium-ion batteries, and a Southeast Asian surfactant network in Vietnam and Indonesia. First-half 2026 results recovered sharply. A Korea Fair Trade Commission cartel case over biofuel tenders, with a possible criminal referral, is the largest unquantified liability.
What the company does. Aekyung Chemical is a mid-sized, diversified intermediate and specialty chemicals producer. Its filings define four strategic operating divisions: Plasticizers, Synthetic Resins, Household (Life) Chemicals, and Bio & Energy. A small "Other" line covers steam sales and an arts, sports and leisure service activity (FY2024 Business Report). FnGuide's company profile (2 Sept 2026) describes a mid-tier company with 11 consolidated subsidiaries producing phthalic anhydride, plasticizers, unsaturated polyester resin and surfactants. It credits the company with the leading domestic share in phthalic anhydride and sole domestic supply of isocyanate hardeners.
The company's own description (paraphrased). Recruitment and corporate materials present Aekyung Chemical as a comprehensive chemical company. It supplies raw materials and materials that are embedded in daily life: plasticizers, biodiesel, composite-material resins, surfactants and battery anode materials. It runs global operations in Korea, China and Vietnam (Saramin company profile, 2026). The post-merger business description in DART filings stresses expansion into four divisions and a focus on environmentally friendly products.
Independent characterization. In economic terms this is a spread business. The largest division (47.6% of FY2024 revenue) converts ortho-xylene into phthalic anhydride and then, with oxo-alcohols, into PVC plasticizers. Margins depend on the gap between product prices and feedstock costs, and on regional supply and demand. Chinese capacity additions have compressed that gap since 2022. The resin and surfactant divisions are closer to formulated products, with stickier customers and steadier margins, but they are sub-scale by global standards. The Bio & Energy division sells into tender markets created by regulation: the Renewable Fuel Standard (RFS) for diesel blending and the Renewable Portfolio Standard (RPS) for power generation. Demand there is set by policy, and pricing is set by competitive bidding. That bidding process is now the subject of an antitrust case.
Revenue model. Almost all revenue is product sales (manufactured goods plus some traded merchandise). There are no subscription or licensing revenues of note. Services are immaterial and sit within "Other" at 2.6% of FY2024 revenue.
Value chain position. The company is midstream. It buys petrochemical feedstocks (ortho-xylene, alcohols, styrene, glycols), oleochemical feedstocks (palm-derived fatty alcohols and oils, used cooking oil) and sells to converters and formulators.
Customer types and end-markets.
Strategy
Stated themes (paraphrased from company statements). Management has said it will build a global production system and improve cost competitiveness in existing businesses. It will also keep developing high-value products, and move quickly on TPC and hard carbon (company comment in DealSite, Sept 2025). A group spokesperson described the company as laying a technology base for future growth (Lead Economy, Apr 2026).
Initiatives in the last 24 months.
FY2025 revenue was about 36% of that figure. No current-year guidance was found. Korean mid-caps rarely give one.
Cost programmes. No quantified cost-reduction programme was found in the sources reviewed.
Products & Services
Pricing is negotiated or tender-based, and no list prices are disclosed. Launch years are given only where sourced. Product grades marked "recollection" are from general industry knowledge of the company's range and should be confirmed against the product pages.
Plasticizers division
| Product | Description and use | Target customer | Notes |
|---|---|---|---|
| Phthalic anhydride (PA) | Made from ortho-xylene; feedstock for plasticizers, UPR and alkyd resins, dyes | Plasticizer and resin makers; captive use | Leading domestic share (FnGuide) |
| General phthalate plasticizers (DOP/DEHP, DINP, DIDP) | PVC softening agents for flooring, sheet, wire and cable, wall covering | PVC converters | Grades: recollection. Commodity products exposed to Chinese supply (DealSite) |
| Non-phthalate plasticizers (DOTP and related, NEO-T brand family) | Terephthalate plasticizers for consumer-contact and regulated uses | Flooring, medical and toy-grade PVC makers | Brand: recollection |
| Recycled-PET-based eco plasticizer | Plasticizer made using waste PET as raw material; in mass production | Customers with recycled-content targets | FnGuide (Sept 2026); company R&D release (Apr 2026); ISCC PLUS and GRS certifications obtained |
| Lubricant base oil (synthetic ester type) | Ester base stocks | Lubricant formulators | Listed in segment definition (FY2024 Business Report) |
| TPC (terephthaloyl chloride) | Key monomer for para-aramid fibre; 15,000 t/yr plant at Ulsan completed March 2026; uses a photo-chlorination ("light") process that suppresses SO2 and HCl by-product formation | Aramid fibre producers | Ilyo Weekly; Lead Economy. FnGuide refers to "chlorinated products" being commercialized |
Synthetic Resins division
| Product | Description and use | Target customer | Notes |
|---|---|---|---|
| Unsaturated polyester resin (UPR) | Thermoset resin for composites (FRP), artificial marble, construction | Composite fabricators | FY2024 Business Report |
| Coating resins (acrylic, alkyd, polyester) | Binder resins for paints | Paint manufacturers | FY2024 Business Report |
| Hardeners (isocyanate type) | Curing agents for polyurethane coatings | Paint and coating makers | Sole domestic supplier per FnGuide |
| Recycled-MMA-based coating resin | Coating resin from regenerated methyl methacrylate | Coatings customers with sustainability targets | Water Journal (2024) |
| Biodegradable fertilizer coating resin | Coating for controlled-release fertilizer; in mass production | Fertilizer producers | Company R&D release (Apr 2026) |
| Fire-safe construction material resin | Building material with improved fire safety; international certification obtained | Construction materials makers | Water Journal (2024) |
| Polyurethane (PU) resins | Listed in the parent-company product mix | Industrial users | JobKorea |
Household Chemicals division
| Product | Description and use | Target customer | Notes |
|---|---|---|---|
| Anionic surfactants (ASCO series, e.g. ASCO1416) | Cleaning actives for detergents and personal care | Detergent and personal-care formulators | Product name appears in FY2024 Business Report |
| Other surfactants (nonionic, amphoteric, specialty) | Formulation ingredients | Home and personal care, industrial | General range: recollection |
| Industrial emulsifiers | Functional raw materials; dedicated development team since the Jan 2026 R&D reorganization | Industrial users | eToday, 23 Jan 2026 |
| Refined glycerin | Co-product of oleochemical and biodiesel chains; humectant and chemical raw material | Personal care, food, pharma, chemicals | FY2024 Business Report |
Bio & Energy division
| Product | Description and use | Target customer | Notes |
|---|---|---|---|
| Biodiesel | Fatty acid methyl ester blended into automotive diesel under the RFS (4% blend in 2026) | Korean refiners, by tender | Money Today, 30 Jul 2026 |
| Bio-heavy oil | Power-generation fuel under the RPS | Power generators, by tender | Same |
| Hard-carbon anode material | Anode material for sodium-ion and lithium-ion batteries; bio-mass-based feedstock; near-spherical particles give good coatability and electrode density; Jeonju plant | Battery cell makers and EV makers (sample testing) | Money Today, Seoul Economic Daily, 4 Dec 2025 |
Other
Steam sales and an arts, sports and leisure service activity (2.6% of FY2024 revenue).
Financial Narrative
All figures are consolidated K-IFRS. FY2021 includes the merged businesses only from 1 November 2021.
Income statement
Sources: Hankyung/NICE consolidated statements; company IR page for FY2023–FY2025 cross-check; FnGuide for FY2025 EBITDA (KRW 41.93 bn) and DPS. FY2024 EPS is shown as zero by the Hankyung feed; 82 is derived from controlling net income of KRW 3.98 bn over about 48.3 m shares.
Margins and growth
Revenue CAGR FY2021–FY2025: about −1.9% (derived). From the FY2022 peak to FY2025: about −12.6% a year (derived).
Balance sheet
FY2023–FY2025 are from the company IR page. FY2021–FY2022 are derived by back-solving from Hankyung/NICE growth rates and debt ratios.
Cash flow
Known investing commitments are the KRW 96.7 bn TPC plant (investment period September 2024 to end-2025), the Indonesian plant purchase (price not disclosed in sources reviewed) and the Jeonju hard-carbon line (amount not disclosed in sources reviewed). The dividend for FY2025 implies a payout of roughly KRW 6.8 bn (derived: KRW 140 on about 48.3 m shares net of treasury).
Ratios
Source: Hankyung/NICE. ROE and ROA here use total net income. The company's own IR page reports ROE of 4.52%, 0.54% and −0.41% for FY2023–FY2025, which is on a controlling-interest basis. Both are shown because they differ. ROIC and net debt/EBITDA: not calculable without the debt and cash figures. The cash conversion cycle is derived from the three turnover ratios, with payables turnover on a revenue basis as the vendor defines it.
Commentary
Revenue. FY2022 was the peak, lifted by high product prices and the first full year of the merged businesses. Revenue then fell for three straight years, by a cumulative KRW 724 bn. Management attributes this to Chinese capacity additions and weak global demand (Bizhankook; CEO Score Daily).
Gross profit. Gross margin slid only two points (10.2% to 8.2%), but on a shrinking revenue base that cut gross profit by KRW 103 bn from FY2022 to FY2025.
Operating income. SG&A stayed in a KRW 125–131 bn band while gross profit fell, so operating leverage worked in reverse. The FY2025 operating loss came from costs that did not flex, more than from a collapse in gross margin. Quarterly operating results in 2025 were about KRW +3.4 bn, −0.8 bn, −7.3 bn and, by derivation, roughly −5.5 bn.
Pre-tax and net income. FY2025 pre-tax income stayed positive at KRW 5.6 bn because non-operating income (KRW 60.6 bn) exceeded non-operating expense (KRW 44.8 bn). A tax charge of KRW 10.6 bn, larger than pre-tax income, then produced a net loss of KRW 4.9 bn. In FY2024 minority interests took KRW 4.5 bn of the KRW 8.5 bn net income, so controlling-shareholder profit was only KRW 4.0 bn.
Balance sheet. Assets grew every year from FY2022 while equity was flat and then fell, so liabilities funded the investment programme. The liabilities-to-equity ratio rose from 0.69x to 0.95x. The current ratio fell to 1.04x and net working capital to 1.3% of assets, which leaves little liquidity headroom.
Coverage and working capital. Interest coverage fell from 30.8x to 1.1x in FY2024 and turned negative in FY2025. Receivables turnover dropped from 9.3x to 6.0x in FY2025, which lengthened the derived cash conversion cycle by about 24 days. Possible explanations include longer export terms, the timing of year-end sales, or the consolidation of the Indonesian plant.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Main entities |
|---|---|---|
Plasticizers | Plasticizers, phthalic anhydride, lubricant base oil | Aekyung Chemical; Aekyung (Ningbo) Chemical (11.4% of sales) |
Synthetic Resins | Unsaturated polyester resin (UPR), coating resins, hardeners | Aekyung Chemical |
Household Chemicals | Surfactants, refined glycerin | Aekyung Chemical; AK VINA; Indonesian plant from Nov 2025. The filing also lists Aekyung Specialty Paint in this area of the subsidiary table |
Bio & Energy | Biodiesel, bio-heavy oil, hard carbon | Aekyung Chemical |
Other | Steam; arts, sports and leisure services | — |
Revenue by Segment
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Plasticizers revenue (KRW Bn) | 1,014.7 | — | 781.3 | — |
Synthetic Resins revenue (KRW Bn) | — | — | 209.6 | — |
Household Chemicals revenue (KRW Bn) | — | — | 344.0 | — |
Bio & Energy revenue (KRW Bn) | 376.0 | — | 264.0 | — |
Other revenue (KRW Bn, derived residual) | — | — | 43.4 | — |
Total consolidated revenue (KRW Bn) | 2,176.4 | 1,793.7 | 1,642.2 | 1,452.3 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (%)
| Metric | FY2022 | FY2024 |
|---|---|---|
Plasticizers share (%) | 46.6 | 47.6 |
Synthetic Resins share (%) | — | 12.8 |
Household Chemicals share (%) | — | 20.9 |
Bio & Energy share (%) | 17.3 | 16.1 |
Other share (%) | — | 2.6 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 1,570.1 | 2,176.4 | 1,793.7 | 1,642.2 | 1,452.3 |
Cost of sales (KRW Bn) | 1,412.2 | 1,954.3 | 1,617.7 | 1,501.4 | 1,333.3 |
Gross profit (KRW Bn) | 157.9 | 222.1 | 176.1 | 140.8 | 119.0 |
SG&A (KRW Bn) | 64.6 | 127.1 | 131.0 | 125.4 | 129.2 |
Operating income (KRW Bn) | 93.3 | 95.1 | 45.1 | 15.5 | -10.2 |
EBITDA (KRW Bn, derived from margin) | 109.9 | 128.6 | 80.7 | 53.2 | 42.0 |
Pre-tax income (KRW Bn) | 97.6 | 92.8 | 41.0 | 9.3 | 5.6 |
Income tax (KRW Bn) | 20.3 | 33.4 | 8.0 | 0.8 | 10.6 |
Net income (KRW Bn) | 77.3 | 59.4 | 33.0 | 8.5 | -4.9 |
Net income to controlling shareholders (KRW Bn) | 77.4 | 60.1 | 33.1 | 4.0 | -2.9 |
EPS basic (KRW) | 2,302 | 1,249 | 686 | 82 | -61 |
Dividend per share (KRW) | — | — | — | — | 140 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 10.06 | 10.21 | 9.82 | 8.58 | 8.19 |
Operating margin (%) | 5.94 | 4.37 | 2.51 | 0.94 | -0.70 |
EBITDA margin (%) | 7.00 | 5.91 | 4.50 | 3.24 | 2.89 |
Net margin (%) | 4.92 | 2.73 | 1.84 | 0.52 | -0.34 |
Revenue growth (%) | 72.76 | 38.62 | -17.58 | -8.45 | -11.56 |
Operating income growth (%) | 62.23 | 1.96 | -52.61 | -65.69 | — |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (KRW Bn) | 1,244.9 | 1,234.1 | 1,308.4 | 1,356.4 | 1,394.3 |
Total liabilities (KRW Bn) | 555.8 | 505.9 | 572.0 | 615.5 | 677.9 |
Total equity (KRW Bn) | 689.1 | 728.1 | 736.3 | 741.0 | 716.4 |
Book value per share (KRW) | 14,243 | 14,967 | 15,137 | 15,142 | 14,678 |
Margin Analysis (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 14.31 | 8.38 | 4.50 | 1.15 | -0.68 |
ROA (%) | 8.70 | 4.79 | 2.59 | 0.64 | -0.36 |
Current ratio (x) | 1.26 | 1.25 | 1.22 | 1.16 | 1.04 |
Quick ratio (x) | 0.68 | 0.71 | 0.75 | 0.66 | 0.64 |
Total liabilities / equity (x) | 0.81 | 0.69 | 0.78 | 0.83 | 0.95 |
Equity ratio (%) | 55.35 | 59.00 | 56.28 | 54.63 | 51.38 |
Interest coverage (x) | 30.78 | 10.15 | 3.89 | 1.13 | -0.57 |
Asset turnover (x) | 1.77 | 1.76 | 1.41 | 1.23 | 1.06 |
Inventory turnover (x) | 8.88 | 8.14 | 7.43 | 7.36 | 7.09 |
Receivables turnover (x) | 11.76 | 11.05 | 9.46 | 9.27 | 5.97 |
Payables turnover (x) | 15.17 | 15.72 | 14.76 | 15.04 | 15.36 |
Cash conversion cycle (days, derived) | 48 | 55 | 63 | 65 | 89 |
Net working capital / total assets (%) | 9.87 | 9.55 | 8.21 | 5.10 | 1.27 |
Segment Overview — Plasticizers
| Segment | Export | Domestic | Total |
|---|---|---|---|
Plasticizers | 587.7 | 193.5 | 781.3 |
Synthetic Resins | 80.9 | 128.7 | 209.6 |
Household Chemicals | 172.5 | 171.6 | 344.0 |
Bio & Energy | — | — | 264.0 |
Three-segment subtotal (derived) | 841.1 | 493.8 | 1,334.9 |
Revenue by Region
| Metric | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
Plasticizers domestic revenue (KRW Bn) | 469.2 | 237.9 | 193.5 |
Plasticizers total revenue (KRW Bn) | 1,014.7 | — | 781.3 |
Plasticizers export revenue (KRW Bn, derived) | 545.5 | — | 587.7 |
Revenue by Region (Half-Yearly)
| Metric | H1 2024 | H1 2025 |
|---|---|---|
Bio & Energy revenue (KRW Bn) | 131.5 | 84.2 |
Share Price & Returns
| Period | Return (%) |
|---|---|
1 month | 5.83 |
3 months | 12.38 |
6 months | -28.36 |
1 year | 8.90 |
Valuation Snapshot
| Multiple | Value |
|---|---|
P/E | Not meaningful (loss) |
P/B | 0.74 |
EV/EBITDA | 22.54 |
Price/cash flow | 19.01 |
Dividend yield (%) | 1.29 |
Valuation Multiples (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
P/B (x) | 0.76 | 0.59 | — | 0.45 | 0.65 |
EV/EBITDA (x) | 6.75 | 4.72 | 14.09 | 12.56 | 21.12 |
P/E (x) | 4.71 | 7.10 | — | — | — |
Beta | 0.85 | 1.22 | — | 1.32 | 1.12 |
Analyst Conclusions
Guidance and consensus. The company has issued no numerical guidance in the sources reviewed, and there is no broker consensus. The only hard forward indicator is the H1 2026 result.
H1 2026 arithmetic (derived, not reported figures). H1 2025 revenue was KRW 746.2 bn and operating profit KRW 2.7 bn. Applying the reported growth rates gives H1 2026 revenue of roughly KRW 874 bn and operating profit of roughly KRW 48–50 bn. Q1 2026 was KRW 370.6 bn and KRW 5.8 bn. That implies Q2 2026 revenue of about KRW 500 bn and operating profit above KRW 40 bn, which would be the strongest quarter since 2022. FnGuide attributes the improvement partly to RPS-driven Bio & Energy demand. These implied numbers should be checked against the half-year report before being used.
Bull case
-
Earnings have turned. H1 2026 operating profit is many times FY2024's full-year KRW 15.5 bn, on a cost base that did not grow.
-
TPC gives the company a domestic monopoly position in a specialty monomer that Korea used to import entirely, with logistics and lead-time advantages over Chinese supply.
-
At 0.74x book, the market is pricing little value for the hard-carbon and Southeast Asian options.
Bear case
-
The KFTC case could produce a fine that is large relative to a KRW 530 bn market capitalization and KRW 716 bn of equity, and criminal referrals. The amount is unknown and may not be provided for.
-
The core plasticizer business has structural overcapacity. A single strong quarter may reflect temporary spreads or tender timing.
-
The balance sheet has less room than before (liabilities/equity 0.95x, current ratio 1.04x), while three projects still need ramp-up funding and the parent group has reason to keep dividends flowing.
Catalysts and monitorables (next 12 months)
-
KFTC full-commission decision: fine amount, treatment of cover bidding, criminal referral.
-
Q3 2026 report (due by 16 November 2026): whether Q2 profitability held, and any provision.
-
TPC: named customers, qualification and utilization.
-
Hard carbon: first supply contract.
-
Vietnam Lotus Project start-up and Indonesian plant contribution.
-
New CEO's first strategy statement and any cost programme.
-
Receivables and working-capital trend.
-
Plasticizer utilization and domestic share.
Analyst verdict. Aekyung Chemical is a commodity-exposed chemical company trying to convert a decade of in-house research into specialty earnings. The evidence divides into three parts.
The first is the legacy business. From FY2022 to FY2025, revenue fell by a third and the operating margin went from 4.4% to below zero. The cause is well documented: Chinese plasticizer capacity displaced the company in its home market. Utilization near half of capacity shows the problem is structural.
The second is the response. Management built Korea's first TPC plant on schedule, bought a surfactant plant in Indonesia, and moved hard carbon to pilot scale. These are credible steps, and the R&D record behind them is real. None has yet produced disclosed revenue or a named customer.
The third is the 2026 rebound. The half-year numbers imply a very strong second quarter. Until the drivers are read from the filing, it is unsafe to treat this as a new run-rate.
Over all three sits the cartel case. The alleged conduct spans eleven years in a division that contributed about a sixth of revenue. The possible penalty is unquantified, and the outcome is binary in its effect on equity value and on the reputations of management and the board. The mid-year change of chief executive adds a further unknown.
On balance, the investment debate is no longer about whether the company can earn money in 2026. It is about how much of that is durable, and how much the regulator will take. This synthesis is analysis, not an investment recommendation.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Governance Overview
| Item | Detail | Source |
|---|---|---|
Board size | 8 directors | Digital Today via Nate |
Outside directors | 3 (37.5%) | Same |
Audit committee | Composed entirely of outside directors | Same |
New non-executive director | Jung Seok, head of strategic planning at AK Holdings; formerly A.T. Kearney principal, Aekyung Industrial growth strategy, AK Plaza strategy head | Business Post |
Other holding-company director | Min Pung-gi, AK Holdings executive, joined the board at the 2025 AGM | The Bell via CB Insights |
Re-elected outside director | Woo Yong-sang (audit committee member) | GoInsider |
Major Shareholders
| Holder | Shares | Stake (%) |
|---|---|---|
AK Holdings and 11 related parties | 30,302,509 | 62.29 |
Treasury shares | 368,336 | 0.76 |
Other reporting holders (6) | 45,494 | 0.09 |
Foreign ownership (aggregate) | — | 0.44 |
Free float | — | 36.87 |
Competitive Landscape
Competitors by Segment
| Segment | Competitors | Basis |
|---|---|---|
Plasticizers and PA | LG Chem; Hanwha Solutions; OCI (PA); Chinese producers such as Bluesail; UPC Technology and Nan Ya Plastics (Taiwan); global majors BASF, Evonik, ExxonMobil Chemical, Eastman | Industry knowledge; press confirms Chinese producers as the main pressure |
Synthetic resins | Sewon Chemical; other Korean UPR and coating-resin makers; Polynt-Reichhold, AOC (global) | Industry knowledge |
Surfactants | Miwon Commercial; KCI; LG Household & Health Care's captive supply; BASF, Stepan, Kao, Wilmar-related oleochemical producers | Industry knowledge |
Biodiesel and bio-heavy oil | DS Dansuk; SK Eco Prime; SK Chemicals (former business); Emac Solution; JC Chemical; KG Eco Solution | KFTC list of seven respondents |
Hard carbon | Kuraray; Chinese producers (e.g. BTR, Shanshan) | Industry knowledge |
TPC | Chinese merchant suppliers; captive production at global aramid majors | Industry knowledge; Korea previously imported all its TPC (Lead Economy) |
Peer Comparison FY2025
| Dimension | Aekyung Chemical (FY2025) | LG Chem / Hanwha Solutions |
|---|---|---|
Revenue scale | KRW 1.45 trillion | Many times larger; plasticizers are a small part of each |
Operating margin | −0.70% | — |
R&D intensity | 1.6% of revenue | — |
Plasticizer feedstock integration | Integrated back to PA; buys ortho-xylene and alcohols | Stronger upstream integration (alcohols, PVC chain) |
Recent Developments
--



